Article thumbnail

Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: A position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation

By Michael Pignone, Mark J. Alberts, John A. Colwell, Mary Cushman, Silvio E. Inzucchi, Debabrata Mukherjee, Robert S. Rosenson, Craig D. Williams, Peter W. Wilson and M. Sue Kirkman
Topics: Reviews/Commentaries/ADA Statements
Publisher: American Diabetes Association
OAI identifier: oai:pubmedcentral.nih.gov:2875463
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2009). 40. Eikelboom
  2. Altered platelet functionindiabetesmellitus.Diabetes(Suppl. 2) 1976;25:826–831 30. Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007; 357:2482–2494 31. Watala
  3. (2007). Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States,
  4. (2010). Lancet 1998;351: 1755–1762 15. de Gaetano G, Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 2001;357:89–95 16. Sacco